.68 I.Le tacrolimus par voie topique, p.68 ,
Anatomie et physiologie de la peau et de ses annexes, Annales de Dermatologie et de V??n??r??ologie, vol.136, issue.0, pp.247-51, 2007. ,
DOI : 10.1016/S0151-9638(09)72527-X
EMC -Dermatol-Cosmétologie, nov, vol.2, issue.4, pp.204-220, 2005. ,
A descriptive study to characterize segmental vitiligo, Indian Journal of Dermatology, Venereology, and Leprology, vol.78, issue.6 ,
DOI : 10.4103/0378-6323.102362
The epidemiology and genetics of vitiligo, Clinics in Dermatology, vol.15, issue.6, pp.875-883, 1997. ,
DOI : 10.1016/S0738-081X(97)00128-4
Vitiligo: Compendium of clinico-epidemiological features, Indian Journal of Dermatology, Venereology and Leprology, vol.73, issue.3 ,
DOI : 10.4103/0378-6323.32708
Characteristics of genetic epidemiology and genetic models for vitiligo, Journal of the American Academy of Dermatology, vol.51, issue.3, pp.383-90, 2004. ,
DOI : 10.1016/j.jaad.2003.12.044
Evidence for a Susceptibility Gene, SLEV1, on Chromosome 17p13 in Families with Vitiligo-Related Systemic Lupus Erythematosus, The American Journal of Human Genetics, vol.69, issue.6, pp.1401-1407, 2001. ,
DOI : 10.1086/324470
Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2, Human Molecular Genetics, vol.11, issue.6, pp.661-668, 2002. ,
DOI : 10.1093/hmg/11.6.661
Novel Vitiligo Susceptibility Loci on Chromosomes 7 (AIS2) and 8 (AIS3), Confirmation of SLEV1 on Chromosome 17, and Their Roles in an Autoimmune Diathesis, The American Journal of Human Genetics, vol.74, issue.1, pp.188-91, 2004. ,
DOI : 10.1086/381134
STUDY OF HLA CLASS I/II AND T LYMPHOCYTE SUBSETS IN KUWAITI VITILIGO PATIENTS, European Journal of Immunogenetics, vol.19, issue.2, pp.209-222, 1995. ,
DOI : 10.1111/j.1365-2133.1976.tb00822.x
Difference in clinical features and HLA antigens between familial and non-familial vitiligo of non-segmental type, British Journal of Dermatology, vol.89, issue.4, pp.408-418, 1993. ,
DOI : 10.1002/gepi.1370020107
Vitiligo is associated with HLA-A2 and HLA-Dw7 in the Slovak populations, Folia Biol, vol.42, issue.12, pp.23-28, 1996. ,
in Vitiligo-Associated Multiple Autoimmune Disease, New England Journal of Medicine, vol.356, issue.12, pp.1216-1241, 2007. ,
DOI : 10.1056/NEJMoa061592
Autoimmunity as an aetiological factor in vitiligo, Journal of the European Academy of Dermatology and Venereology, vol.124, issue.Suppl, pp.865-76, 2007. ,
DOI : 10.1111/j.1468-3083.2007.02228.x
Evidence for an Autoimmune Pathogenesis of Vitiligo, Pigment Cell Research, vol.128, issue.2, pp.90-100, 2003. ,
DOI : 10.1111/j.1365-2133.2000.03712.x
Oxidative Stress, pp.231-238 ,
DOI : 10.1007/978-3-540-69361-1_27
Vitiligo: A comprehensive overview, Journal of the American Academy of Dermatology, vol.65, issue.3, pp.473-91, 2011. ,
DOI : 10.1016/j.jaad.2010.11.061
The Neurogenic Hypothesis in Segmental Vitiligo, pp.302-307 ,
Higher Plasma Catecholamine and Metabolite Levels in the Early Phase of Nonsegmental Vitiligo, Pigment Cell Research, vol.13, issue.1, pp.28-32, 2000. ,
DOI : 10.1034/j.1600-0749.2000.130106.x
Detection of plasma and urinary monoamines and their metabolites in nonsegmental vitiligo, Acta Dermatovenerol Croat ADC, vol.20, issue.1, pp.14-20, 2012. ,
Perturbed 6-Tetrahydrobiopterin Recycling via Decreased Dihydropteridine Reductase in Vitiligo: More Evidence for H2O2 Stress, Journal of Investigative Dermatology, vol.122, issue.2, pp.307-320, 2004. ,
DOI : 10.1046/j.0022-202X.2004.22230.x
Successful Treatment of Oxidative Stress in Vitiligo, Skin Pharmacology and Physiology, vol.12, issue.3, pp.132-140, 1999. ,
DOI : 10.1159/000029867
Oxidative stress level and tyrosinase activity in vitiligo patients, Indian J Dermatol, vol.55, issue.1, pp.15-24, 2010. ,
Mitochondrial Impairment in Peripheral Blood Mononuclear Cells During the Active Phase of Vitiligo, Journal of Investigative Dermatology, vol.117, issue.4, pp.908-921, 2001. ,
DOI : 10.1046/j.0022-202x.2001.01459.x
Vitiligo, reactive oxygen species and T-cells, Clinical Science, vol.174, issue.3, pp.99-120, 1979. ,
DOI : 10.1182/blood-2006-07-034066
Heinrich K??bner und der "isomorphe Reizeffekt", Der Hautarzt, vol.54, issue.3, pp.274-282, 2003. ,
DOI : 10.1007/s00105-002-0470-5
The Koebner phenomenon: review of the literature, Journal of the European Academy of Dermatology and Venereology, vol.19, issue.3, pp.241-249, 2002. ,
DOI : 10.1046/j.1473-2165.2002.00406.x
Clinical significance of Koebner???s phenomenon in vitiligo, British Journal of Dermatology, vol.167, issue.5, pp.1017-1041, 2012. ,
DOI : 10.1111/j.1365-2133.2012.11111.x
Koebner phenomenon in vitiligo in an Indian population, Clinical and Experimental Dermatology, vol.165, issue.5, pp.554-559, 2013. ,
DOI : 10.1111/j.1365-2230.2012.04422.x
Vitiligo, The Lancet, vol.386, issue.9988, pp.74-84, 2015. ,
DOI : 10.1016/S0140-6736(14)60763-7
Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference, Pigment Cell & Melanoma Research, vol.7, issue.Suppl, pp.1-13, 2012. ,
DOI : 10.1111/j.1755-148X.2012.00997.x
Segmental vitiligo: Clinical findings in 208 patients, Journal of the American Academy of Dermatology, vol.35, issue.5, pp.671-675, 1996. ,
DOI : 10.1016/S0190-9622(96)90718-5
Clinical features of vitiligo, Clinics in Dermatology, vol.15, issue.6, pp.891-898, 1997. ,
DOI : 10.1016/S0738-081X(97)00130-2
Classification of segmental vitiligo on the face: clues for prognosis, British Journal of Dermatology, vol.57, issue.Suppl. 2, pp.1004-1013, 2011. ,
DOI : 10.1111/j.1365-2133.2010.10202.x
Vitiligo: A review of the published work, The Journal of Dermatology, vol.171, issue.6S, pp.419-450, 2011. ,
DOI : 10.1111/j.1346-8138.2010.01139.x
Latent class analysis of a series of 717 patients with vitiligo allows the identification of two clinical subtypes, Pigment Cell & Melanoma Research, vol.20, issue.1, pp.134-143, 2014. ,
DOI : 10.1111/pcmr.12186
Assessment methods for the evaluation of vitiligo, Journal of the European Academy of Dermatology and Venereology, vol.14, issue.12, pp.1463-71, 2012. ,
DOI : 10.1111/j.1468-3083.2012.04505.x
Guideline for the diagnosis and management of vitiligo, British Journal of Dermatology, vol.5, issue.5, pp.1051-76, 2008. ,
DOI : 10.1111/j.1365-2133.2008.08881.x
Topical corticosteroids, pp.327-357 ,
Vitiligo nonsurgical treatment: a review of latest treatment researches, Dermatologic Therapy, vol.168, issue.5, pp.298-303, 2014. ,
DOI : 10.1111/dth.12143
Vitamine D analogues, pp.339-381 ,
PUVA and related treatments, pp.345-51 ,
Photo(chemo)therapy for vitiligo, Photodermatology, Photoimmunology & Photomedicine, vol.15, issue.(Suppl 1), pp.261-77, 2011. ,
DOI : 10.1111/j.1600-0781.2011.00606.x
The development of guidelines for the treatment of vitiligo Clinical Epidemiology Unit of the Istituto Dermopatico dell'Immacolata-Istituto di Recovero e Cura a Carattere Scientifico (IDI-IRCCS) and the Archives of Dermatology, Arch Dermatol. déc, vol.135, issue.12, pp.1514-1535, 1999. ,
UVB total Body and Targeted phototherapies, pp.353-65 ,
Effectiveness of a 308-nm excimer laser in treatment of vitiligo: a review, Lasers in Medical Science, vol.24, issue.6, pp.1035-1076, 2013. ,
DOI : 10.1007/s10103-012-1185-1
Surgical therapies, pp.393-415 ,
Surgical management of vitiligo, Journal of the American Academy of Dermatology, vol.57, issue.6, pp.1105-1111, 2007. ,
DOI : 10.1016/j.jaad.2007.06.019
Vitiligo: A comprehensive overview, Journal of the American Academy of Dermatology, vol.65, issue.3, pp.493-514, 2011. ,
DOI : 10.1016/j.jaad.2010.10.043
Vitiligo, American Journal of Clinical Dermatology, vol.135, issue.3, pp.167-81, 2001. ,
DOI : 10.2165/00128071-200102030-00006
Microskin grafting for Vitiligo ,
DOI : 10.1007/978-1-84882-605-2
Thin and Ultra Thin Split Thickness Skin Grafts (STSG-UT, STSG-T) ,
DOI : 10.1007/978-1-84882-605-2_5
Split Thickness Skin Sheet Grafting, Microskin grafting for Vitiligo ,
Vitamins and Antioxydants : topical and systemic, pp.369-74 ,
Treatment of Vitiligo Vulgaris with Narrow Band UVB (311nm) for One Year and the Effect of Addition of Folic Acid and Vitamin B12, Acta Dermato-Venereologica, vol.82, issue.5, pp.369-72, 2002. ,
DOI : 10.1080/000155502320624113
A Survey of Ultraviolet Absorbers in Commercially Available Sun Products, International Journal of Dermatology, vol.73, issue.4, pp.247-55, 1983. ,
DOI : 10.1111/j.1600-0536.1980.tb05600.x
Combined Therapies for Vitiligo, pp.417-438 ,
Depigmenting Agents, pp.439-481 ,
DOI : 10.1007/978-3-540-69361-1_52
Les lasers en dermatologie, Ann Dermatol Vénéréologie, vol.138, issue.11, p.807, 2011. ,
Tacrolimus: a review of its use for the management of dermatoses, Journal of the European Academy of Dermatology and Venereology, vol.92, issue.2, pp.100-114, 2002. ,
DOI : 10.1016/S0041-1345(98)01917-4
Tacrolimus ointment promotes repigmentation of vitiligo in children: A review of 57 cases, Journal of the American Academy of Dermatology, vol.51, issue.5, pp.760-766, 2004. ,
DOI : 10.1016/j.jaad.2004.05.036
FK506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes: possible mechanisms of how tacrolimus ointment induces repigmentation in patients with vitiligo, British Journal of Dermatology, vol.30, issue.Suppl., pp.498-505, 2005. ,
DOI : 10.1111/j.1365-2133.2005.06739.x
Calcineurin inhibitors, pp.331-339 ,
FK506 increases pigmentation and migration of human melanocytes, British Journal of Dermatology, vol.155, issue.5, pp.1037-1077, 2006. ,
DOI : 10.1111/j.1365-2133.2004.06280.x
Topical tacrolimus for treatment of childhood vitiligo in Asians, Clinical and Experimental Dermatology, vol.139, issue.6, pp.589-92, 2004. ,
DOI : 10.1046/j.1523-1747.1998.00323.x
Tacrolimus-Induced Hyperpigmentation in a Patch of Vitiligo, SKINmed, vol.74, issue.2, pp.93-97, 2008. ,
DOI : 10.1111/j.1365-2133.2005.06739.x
Response of vitiligo to once- vs. twice-daily topical tacrolimus: a controlled prospective, randomized, observer-blinded trial, Journal of the European Academy of Dermatology and Venereology, vol.153, issue.Suppl., pp.951-954, 2009. ,
DOI : 10.1111/j.1468-3083.2009.03138.x
Repigmentation of pretibial vitiligo with calcineurin inhibitors under occlusion, JDDG, vol.3, issue.5, pp.383-388, 2008. ,
DOI : 10.1016/j.jaad.2005.06.013
Tacrolimus ointment 0.1% produces repigmentation in patients with vitiligo: results of a prospective patient series, Cutis. févr, vol.71, issue.2, pp.158-62, 2003. ,
Occlusive Treatment Enhances Efficacy of Tacrolimus 0.1% Ointment in Adult Patients with Vitiligo: Results of a Placebo-controlled 12-month Prospective Study, Acta Dermato Venereologica, vol.88, issue.5, pp.474-483, 2008. ,
DOI : 10.2340/00015555-0464
Maintenance Therapy of Adult Vitiligo with 0.1% Tacrolimus Ointment: A Randomized, Double Blind, Placebo???Controlled Study, Journal of Investigative Dermatology, vol.135, issue.4, pp.970-974, 2015. ,
DOI : 10.1038/jid.2014.527
Combined Excimer Laser and Topical Tacrolimus for the Treatment of Vitiligo, Dermatologic Surgery, vol.30, issue.2, pp.130-135, 2004. ,
DOI : 10.1097/00042728-200402000-00002
Topical Tacrolimus and the 308-nm Excimer Laser, Archives of Dermatology, vol.140, issue.9, pp.1065-1074, 2004. ,
DOI : 10.1001/archderm.140.9.1065
Repigmentation of chronic vitiligo lesions by following tacrolimus plus ultraviolet-B-narrow-band, Photodermatology, Photoimmunology and Photomedicine, vol.102, issue.1, pp.35-41, 2003. ,
DOI : 10.1046/j.1365-2133.2001.04286.x
Targeted and combination treatments for vitiligo???Comparative evaluation of different current modalities in 458 subjects, Dermatologic Therapy, vol.142, issue.1, pp.20-26, 2008. ,
DOI : 10.1111/j.1529-8019.2008.00198.x
Effect of Tacrolimus on Vitiligo in Absence of UV Radiation Exposure, Archives of Dermatology, vol.143, issue.1, p.119, 2007. ,
DOI : 10.1001/archderm.143.1.119
Topical tacrolimus and vitiligo: Our experience in sixty cases, G Ital Dermatol Venereol, vol.142, issue.6, pp.621-626, 2007. ,
[Vitiligo. Treatment of 12 cases with topical tacrolimus]. Actas Dermo-Sifiliográficas, avr, vol.96, issue.3, pp.159-63, 2005. ,
Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines, Journal of the American Academy of Dermatology, vol.51, issue.1, pp.52-61, 2004. ,
DOI : 10.1016/j.jaad.2003.12.031
A Double-blind Randomized Trial of 0.1% Tacrolimus vs 0.05% Clobetasol for the Treatment of Childhood Vitiligo, Archives of Dermatology, vol.139, issue.5, pp.581-586, 2003. ,
DOI : 10.1001/archderm.139.5.581
Successful Treatment of Vitiligo With 0.1% Tacrolimus Ointment, Archives of Dermatology, vol.139, issue.5, pp.571-575, 2003. ,
DOI : 10.1001/archderm.139.5.571
Topical tacrolimus for repigmentation of vitiligo, Journal of the American Academy of Dermatology, vol.47, issue.5, pp.789-91, 2002. ,
DOI : 10.1067/mjd.2002.126250
Repigmentation of Vitiligo with Topical Tacrolimus, Dermatology, vol.205, issue.3 ,
DOI : 10.1159/000065845
A double-blind, randomized, placebo-controlled trial of topical tacrolimus 0??1% vs. clobetasol propionate 0??05% in childhood vitiligo, British Journal of Dermatology, vol.27, issue.3, pp.626-658, 2011. ,
DOI : 10.1111/j.1365-2133.2011.10351.x
Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of 110 patients, Journal of the European Academy of Dermatology and Venereology, vol.153, issue.7, pp.916-936, 2007. ,
DOI : 10.1111/j.1468-3083.2006.02101.x
A Randomized, Placebo-Controlled, Double-blind Trial Comparing Narrowband UV-B Plus 0.1% Tacrolimus Ointment With Narrowband UV-B Plus Placebo in the Treatment of Generalized Vitiligo, Archives of Dermatology, vol.142, issue.7, pp.927-936, 2006. ,
DOI : 10.1001/archderm.142.7.927
Lack of Efficacy of Tacrolimus in the Treatment of Vitiligo in the Absence of UV-B Exposure, Archives of Dermatology, vol.142, issue.2, pp.252-255, 2006. ,
DOI : 10.1001/archderm.142.2.252
Triple Combination of Systemic Corticosteroids, Excimer Laser, and Topical Tacrolimus in the Treatment of Recently Developed Localized Vitiligo, Annals of Dermatology, vol.27, issue.1, pp.104-111, 2015. ,
DOI : 10.5021/ad.2015.27.1.104
Combination therapy with 308-nm excimer laser, topical tacrolimus, and short-term systemic corticosteroids for segmental vitiligo: A retrospective study of 159 patients, Journal of the American Academy of Dermatology, vol.73, issue.1, pp.76-82, 2015. ,
DOI : 10.1016/j.jaad.2015.04.008